Content about Metabolic syndrome

December 7, 2011

Women who work a rotating schedule that includes three or more night shifts per month, in addition to day and evening working hours in that month, may have an increased risk of developing Type 2 diabetes when compared with women who only worked days or evenings.

BOSTON — Women who work a rotating schedule that includes three or more night shifts per month, in addition to day and evening working hours in that month, may have an increased risk of developing Type 2 diabetes when compared with women who only work days or evenings, according to a new study led by researchers at Harvard's School of Public Health that was released Tuesday.

In addition, the researchers found that extended years of rotating night shift work was associated with weight gain, which may contribute to the increased risk of Type 2 diabetes.

November 9, 2011

Teenagers that consume a fiber-rich diet are less likely to develop metabolic syndrome, according to a new study published in the Journal of the American Dietetic Association.

NEW YORK — Teenagers that consume a fiber-rich diet are less likely to develop metabolic syndrome, according to a new study published in the Journal of the American Dietetic Association.

June 13, 2011

Men with prostate cancer are at a higher risk of developing diabetes or diabetes risk factors if they receive a therapy designed to block the production of testosterone, a new study has suggested.

BOSTON — Men with prostate cancer are at a higher risk of developing diabetes or diabetes risk factors if they receive a therapy designed to block the production of testosterone, a new study has suggested.

September 1, 2010

The National Center for Complementary and Alternative Medicine's small-business technology transfer program, part of the...

EMERYVILLE, Calif. The National Center for Complementary and Alternative Medicine's small-business technology transfer program, part of the National Institutes of Health, has given a researcher and a drug maker a grant to develop drugs for obesity and metabolic syndrome in women.